Authors:
Dagenais, C
Zong, J
Ducharme, J
Pollack, GM
Citation: C. Dagenais et al., Effect of mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds, PHARM RES, 18(7), 2001, pp. 957-963
Citation: C. Dagenais et al., Uptake and efflux of the peptidic delta-opioid receptor agonist [D-penicillamine(2,5)]-enkephalin at the murine blood-brain barrier by in situ perfusion, NEUROSCI L, 301(3), 2001, pp. 155-158
Citation: Gl. Fraser et al., The effects of delta agonists on locomotor activity in habituated and non-habituated rats, LIFE SCI, 67(8), 2000, pp. 913-922
Authors:
Plobeck, N
Delorme, D
Wei, ZY
Yang, H
Zhou, F
Schwarz, P
Gawell, L
Gagnon, H
Pelcman, B
Schmidt, R
Yue, SY
Walpole, C
Brown, W
Zhou, E
Labarre, M
Payza, K
St-Onge, S
Kamassah, A
Morin, PE
Projean, D
Ducharme, J
Roberts, E
Citation: N. Plobeck et al., New diarylmethylpiperazines as potent and selective nonpeptidic delta opioid receptor agonists with increased in vitro metabolic stability, J MED CHEM, 43(21), 2000, pp. 3878-3894
Authors:
Wei, ZY
Brown, W
Takasaki, B
Plobeck, N
Delorme, D
Zhou, F
Yang, H
Jones, P
Gawell, L
Gagnon, H
Schmidt, R
Yue, SY
Walpole, C
Payza, K
St-Onge, S
Labarre, M
Godbout, C
Jakob, A
Butterworth, J
Kamassah, A
Morin, PE
Projean, D
Ducharme, J
Roberts, E
Citation: Zy. Wei et al., N,N-diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide: A novel, exceptionally selective, potent delta opioid receptor agonist with oral bioavailability and its analogues, J MED CHEM, 43(21), 2000, pp. 3895-3905
Citation: J. Ducharme, Canadian Association of Emergency Physicians Guidelines for the acute management of migraine headache, J EMERG MED, 17(1), 1999, pp. 137-144
Authors:
Innes, G
Murphy, M
Nijssen-Jordan, C
Ducharme, J
Drummond, A
Citation: G. Innes et al., Procedural sedation and analgesia in the emergency department. Canadian consensus guidelines, J EMERG MED, 17(1), 1999, pp. 145-156
Authors:
Beveridge, R
Ducharme, J
Janes, L
Beaulieu, S
Walter, S
Citation: R. Beveridge et al., Reliability of the Canadian emergency department triage and acuity scale: Interrater agreement, ANN EMERG M, 34(2), 1999, pp. 155-159
Authors:
Sussman, G
Shurman, J
Creed, MR
Larsen, LS
Ferrer-Brechner, T
Noll, D
Allegra, J
Montgomery, R
Schreck, D
Grafstein, E
Ramalanjaona, G
Patel, V
Ducharme, J
Ortenwall, P
Foster, E
Ames, M
Citation: G. Sussman et al., Intravenous ondansetron for the control of opioid-induced nausea and vomiting, CLIN THER, 21(7), 1999, pp. 1216-1227